Literature DB >> 11390576

Genomic features of intertypic recombinant sabin poliovirus strains excreted by primary vaccinees.

N S Cuervo1, S Guillot, N Romanenkova, M Combiescu, A Aubert-Combiescu, M Seghier, V Caro, R Crainic, F Delpeyroux.   

Abstract

The trivalent oral poliomyelitis vaccine (OPV) contains three different poliovirus serotypes. It use therefore creates particularly favorable conditions for mixed infection of gut cells, and indeed intertypic vaccine-derived recombinants (VdRec) have been frequently found in patients with vaccine-associated paralytic poliomyelitis. Nevertheless, there have not been extensive searches for VdRec in healthy vaccinees following immunization with OPV. To determine the incidence of VdRec and their excretion kinetics in primary vaccinees, and to establish the general genomic features of the corresponding recombinant genomes, we characterized poliovirus isolates excreted by vaccinees following primary immunization with OPV. Isolates were collected from 67 children 2 to 60 days following vaccination. Recombinant strains were identified by multiple restriction fragment length polymorphism assays. The localization of junction sites in recombinant genomes was also determined. VdRec excreted by vaccinees were first detected 2 to 4 days after vaccination. The highest rate of recombinants was on day 14. The frequency of VdRec depends strongly on the serotype of the analyzed isolates (2, 53, and 79% of recombinant strains in the last-excreted type 1, 2, and 3 isolates, respectively). Particular associations of genomic segments were preferred in the recombinant genomes, and recombination junctions were found in the genomic region encoding the nonstructural proteins. Recombination junctions generally clustered in particular subgenomic regions that were dependent on the serotype of the isolate and/or on the associations of genomic segments in recombinants. Thus, VdRec are frequently excreted by vaccinees, and the poliovirus replication machinery requirements or selection factors appear to act in vivo to shape the features of the recombinant genomes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11390576      PMCID: PMC114290          DOI: 10.1128/JVI.75.13.5740-5751.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  49 in total

Review 1.  Evolutionary aspects of recombination in RNA viruses.

Authors:  Michael Worobey; Edward C Holmes
Journal:  J Gen Virol       Date:  1999-10       Impact factor: 3.891

Review 2.  Paradoxes of the replication of picornaviral genomes.

Authors:  V I Agol; A V Paul; E Wimmer
Journal:  Virus Res       Date:  1999-08       Impact factor: 3.303

Review 3.  Picornavirus RNA translation: roles for cellular proteins.

Authors:  G J Belsham; N Sonenberg
Journal:  Trends Microbiol       Date:  2000-07       Impact factor: 17.079

4.  Evolution of circulating wild poliovirus and of vaccine-derived poliovirus in an immunodeficient patient: a unifying model.

Authors:  G V Gavrilin; E A Cherkasova; G Y Lipskaya; O M Kew; V I Agol
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

5.  Genetic recombination with poliovirus type 1. Studies of crosses between a normal horse serum-resistant mutant and several guanidine-resistant mutants of the same strain.

Authors:  N LEDINKO
Journal:  Virology       Date:  1963-05       Impact factor: 3.616

6.  Genetic recombination with Newcastle disease virus, polioviruses, and influenza.

Authors:  G K HIRST
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1962

7.  Genetic transfer of guanidine resistance from type 2 to type 1 poliovirus.

Authors:  D Sergiescu; F Horodniceanu; R Klein; R Crainic
Journal:  Arch Gesamte Virusforsch       Date:  1966

8.  Natural genetic exchanges between vaccine and wild poliovirus strains in humans.

Authors:  S Guillot; V Caro; N Cuervo; E Korotkova; M Combiescu; A Persu; A Aubert-Combiescu; F Delpeyroux; R Crainic
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

9.  'Primer alignment-and-extension': a novel mechanism of viral RNA recombination responsible for the rescue of inactivated poliovirus cDNA clones.

Authors:  Alessandra Pierangeli; M Bucci; M Forzan; P Pagnotti; M Equestre; R Pérez Bercoff
Journal:  J Gen Virol       Date:  1999-08       Impact factor: 3.891

10.  The kissing-loop motif is a preferred site of 5' leader recombination during replication of SL3-3 murine leukemia viruses in mice.

Authors:  A H Lund; J G Mikkelsen; J Schmidt; M Duch; F S Pedersen
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

View more
  66 in total

1.  Isolation of an intertypic poliovirus capsid recombinant from a child with vaccine-associated paralytic poliomyelitis.

Authors:  Javier Martín; Elena Samoilovich; Glynis Dunn; Angie Lackenby; Esphir Feldman; Alan Heath; Ekaterina Svirchevskaya; Gill Cooper; Marina Yermalovich; Philip D Minor
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

2.  RNA recombination plays a major role in genomic change during circulation of coxsackie B viruses.

Authors:  M Steven Oberste; Silvia Peñaranda; Mark A Pallansch
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

Review 3.  Viral quasispecies evolution.

Authors:  Esteban Domingo; Julie Sheldon; Celia Perales
Journal:  Microbiol Mol Biol Rev       Date:  2012-06       Impact factor: 11.056

4.  Correlation of mutations and recombination with growth kinetics of poliovirus vaccine strains.

Authors:  V Pliaka; Z Kyriakopoulou; D Tsakogiannis; I G A Ruether; C Gartzonika; S Levidiotou-Stefanou; A Krikelis; P Markoulatos
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-09-05       Impact factor: 3.267

5.  Circulation of type 1 vaccine-derived poliovirus in the Philippines in 2001.

Authors:  Hiroyuki Shimizu; Bruce Thorley; Fem Julia Paladin; Kerri Anne Brussen; Vicki Stambos; Lilly Yuen; Andi Utama; Yoshio Tano; Minetaro Arita; Hiromu Yoshida; Tetsuo Yoneyama; Agnes Benegas; Sigrun Roesel; Mark Pallansch; Olen Kew; Tatsuo Miyamura
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

6.  High frequency of human enterovirus species C circulation in Madagascar.

Authors:  Mala Rakoto-Andrianarivelo; Dominique Rousset; Richter Razafindratsimandresy; Stéphane Chevaliez; Sophie Guillot; Jean Balanant; Francis Delpeyroux
Journal:  J Clin Microbiol       Date:  2005-01       Impact factor: 5.948

7.  Membrane adsorption with direct cell culture combined with reverse transcription-PCR as a fast method for identifying enteroviruses from sewage.

Authors:  D Papaventsis; N Siafakas; P Markoulatos; G T Papageorgiou; C Kourtis; E Chatzichristou; C Economou; S Levidiotou
Journal:  Appl Environ Microbiol       Date:  2005-01       Impact factor: 4.792

8.  Evolution of 2B and 2C genomic parts of species B Coxsackie viruses. Phylogenetic study and comparison with other regions.

Authors:  Eugenia Bolanaki; Christine Kottaridi; Panayotis Markoulatos; Lukas Margaritis; Theodoros Katsorchis
Journal:  Virus Genes       Date:  2006-06       Impact factor: 2.332

9.  Use of a multiple restriction fragment length polymorphism method for detecting vaccine-derived polioviruses in clinical samples.

Authors:  Natalia I Romanenkova; Sophie Guillot; Nadejda R Rozaeva; Radu Crainic; Maina A Bichurina; Francis Delpeyroux
Journal:  J Clin Microbiol       Date:  2006-09-06       Impact factor: 5.948

10.  Recombination in circulating enteroviruses.

Authors:  Alexander N Lukashev; Vasilii A Lashkevich; Olga E Ivanova; Galina A Koroleva; Ari E Hinkkanen; Jorma Ilonen
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.